Cohen Capital Management’s AbbVie ABBV Stock Holding History

Cohen Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Hold	10,042	–	–	0.34%	62
2026 Q1	$2.18M	Buy	10,042 +204	+2%	+$45.3K	0.34%	66
2025 Q4	$2.25M	Hold	9,838	–	–	0.34%	60
2025 Q3	$2.28M	Sell	9,838 -60	-0.6%	-$12.2K	0.36%	59
2025 Q2	$1.84M	Hold	9,898	–	–	0.3%	62
2025 Q1	$2.07M	Hold	9,898	–	–	0.36%	62
2024 Q4	$1.76M	Sell	9,898 -130	-1%	-$23.9K	0.29%	69
2024 Q3	$1.98M	Hold	10,028	–	–	0.32%	66
2024 Q2	$1.72M	Hold	10,028	–	–	0.3%	72
2024 Q1	$1.83M	Hold	10,028	–	–	0.32%	70
2023 Q4	$1.55M	Hold	10,028	–	–	0.3%	72
2023 Q3	$1.49M	Hold	10,028	–	–	0.31%	74
2023 Q2	$1.35M	Hold	10,028	–	–	0.26%	77
2023 Q1	$1.6M	Sell	10,028 -10	-0.1%	-$1.53K	0.32%	70
2022 Q4	$1.62M	Hold	10,038	–	–	0.33%	71
2022 Q3	$1.35M	Hold	10,038	–	–	0.3%	78
2022 Q2	$1.54M	Hold	10,038	–	–	0.31%	77
2022 Q1	$1.63M	Buy	+10,038	New	+$1.46M	0.28%	84

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cohen Capital Management's ABBV Position: Q2 2026 in Review

Cohen Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 10,042 shares worth $2.53M. The position accounts for 0.34% of the portfolio, ranked #62.

Cohen Capital Management first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cohen Capital Management held 10,042 shares of AbbVie worth $2.53M as of Q2 2026.
Cohen Capital Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.34% of Cohen Capital Management's portfolio in Q2 2026, its #62 holding.
Cohen Capital Management first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cohen Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.